vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and ZIONS BANCORPORATION, NATIONAL ASSOCIATION (ZION). Click either name above to swap in a different company.
ZIONS BANCORPORATION, NATIONAL ASSOCIATION is the larger business by last-quarter revenue ($891.0M vs $829.0M, roughly 1.1× Acadia Healthcare Company, Inc.). ZIONS BANCORPORATION, NATIONAL ASSOCIATION runs the higher net margin — 29.5% vs 0.5%, a 29.0% gap on every dollar of revenue. On growth, ZIONS BANCORPORATION, NATIONAL ASSOCIATION posted the faster year-over-year revenue change (8.7% vs 7.5%). Over the past eight quarters, ZIONS BANCORPORATION, NATIONAL ASSOCIATION's revenue compounded faster (9.6% CAGR vs 2.0%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Zions Bancorporation is an American national bank headquartered in Salt Lake City, Utah. It operates as a national bank rather than as a bank holding company and does business under the following seven brands: Zions Bank, Amegy Bank of Texas, California Bank and Trust, National Bank of Arizona, Nevada State Bank, Vectra Bank Colorado, and the Commerce Bank of Washington.
ACHC vs ZION — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $891.0M |
| Net Profit | $4.5M | $263.0M |
| Gross Margin | — | — |
| Operating Margin | — | — |
| Net Margin | 0.5% | 29.5% |
| Revenue YoY | 7.5% | 8.7% |
| Net Profit YoY | -50.8% | 21.8% |
| EPS (diluted) | $0.05 | $1.77 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $891.0M | ||
| Q3 25 | $851.6M | $861.0M | ||
| Q2 25 | $869.2M | $838.0M | ||
| Q1 25 | $770.5M | $795.0M | ||
| Q4 24 | $774.2M | $820.0M | ||
| Q3 24 | $815.6M | $792.0M | ||
| Q2 24 | $796.0M | $777.0M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $263.0M | ||
| Q3 25 | $36.2M | $222.0M | ||
| Q2 25 | $30.1M | $244.0M | ||
| Q1 25 | $8.4M | $170.0M | ||
| Q4 24 | $32.6M | $216.0M | ||
| Q3 24 | $68.1M | $214.0M | ||
| Q2 24 | $78.5M | $201.0M |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | — | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | 5.8% | — | ||
| Q1 25 | 1.7% | — | ||
| Q4 24 | 4.9% | — | ||
| Q3 24 | 12.1% | — | ||
| Q2 24 | 13.4% | — |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 29.5% | ||
| Q3 25 | 4.3% | 25.8% | ||
| Q2 25 | 3.5% | 29.1% | ||
| Q1 25 | 1.1% | 21.4% | ||
| Q4 24 | 4.2% | 26.3% | ||
| Q3 24 | 8.4% | 27.0% | ||
| Q2 24 | 9.9% | 25.9% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $1.77 | ||
| Q3 25 | $0.40 | $1.48 | ||
| Q2 25 | $0.33 | $1.63 | ||
| Q1 25 | $0.09 | $1.13 | ||
| Q4 24 | $0.36 | $1.34 | ||
| Q3 24 | $0.74 | $1.37 | ||
| Q2 24 | $0.85 | $1.28 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | $1.5B |
| Stockholders' EquityBook value | $2.0B | $7.2B |
| Total Assets | $5.5B | $89.0B |
| Debt / EquityLower = less leverage | 1.29× | 0.21× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.5B | ||
| Q3 25 | $2.3B | $1.5B | ||
| Q2 25 | $2.3B | $970.0M | ||
| Q1 25 | $2.2B | $964.0M | ||
| Q4 24 | $2.0B | $950.0M | ||
| Q3 24 | $1.9B | $548.0M | ||
| Q2 24 | $1.8B | $546.0M |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $7.2B | ||
| Q3 25 | $3.1B | $6.9B | ||
| Q2 25 | $3.1B | $6.6B | ||
| Q1 25 | $3.0B | $6.3B | ||
| Q4 24 | $3.1B | $6.1B | ||
| Q3 24 | $3.0B | $6.4B | ||
| Q2 24 | $3.0B | $6.0B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $89.0B | ||
| Q3 25 | $6.4B | $88.5B | ||
| Q2 25 | $6.3B | $88.9B | ||
| Q1 25 | $6.1B | $88.0B | ||
| Q4 24 | $6.0B | $88.8B | ||
| Q3 24 | $5.9B | $87.0B | ||
| Q2 24 | $5.7B | $87.6B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.21× | ||
| Q3 25 | 0.74× | 0.21× | ||
| Q2 25 | 0.74× | 0.15× | ||
| Q1 25 | 0.72× | 0.15× | ||
| Q4 24 | 0.64× | 0.16× | ||
| Q3 24 | 0.62× | 0.09× | ||
| Q2 24 | 0.62× | 0.09× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $1.1B |
| Free Cash FlowOCF − Capex | — | $952.0M |
| FCF MarginFCF / Revenue | — | 106.8% |
| Capex IntensityCapex / Revenue | — | 13.6% |
| Cash ConversionOCF / Net Profit | 13.78× | 4.08× |
| TTM Free Cash FlowTrailing 4 quarters | — | $1.4B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $1.1B | ||
| Q3 25 | $73.2M | $438.0M | ||
| Q2 25 | $133.5M | $-62.0M | ||
| Q1 25 | $11.5M | $179.0M | ||
| Q4 24 | $116.7M | $1.1B | ||
| Q3 24 | $163.1M | $119.0M | ||
| Q2 24 | $171.1M | $251.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $952.0M | ||
| Q3 25 | $-63.0M | $413.0M | ||
| Q2 25 | $-34.2M | $-93.0M | ||
| Q1 25 | $-163.2M | $152.0M | ||
| Q4 24 | $-86.8M | $1.1B | ||
| Q3 24 | $-27.1M | $97.0M | ||
| Q2 24 | $16.9M | $234.0M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 106.8% | ||
| Q3 25 | -7.4% | 48.0% | ||
| Q2 25 | -3.9% | -11.1% | ||
| Q1 25 | -21.2% | 19.1% | ||
| Q4 24 | -11.2% | 128.2% | ||
| Q3 24 | -3.3% | 12.2% | ||
| Q2 24 | 2.1% | 30.1% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 13.6% | ||
| Q3 25 | 16.0% | 2.9% | ||
| Q2 25 | 19.3% | 3.7% | ||
| Q1 25 | 22.7% | 3.4% | ||
| Q4 24 | 26.3% | 11.8% | ||
| Q3 24 | 23.3% | 2.8% | ||
| Q2 24 | 19.4% | 2.2% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 4.08× | ||
| Q3 25 | 2.02× | 1.97× | ||
| Q2 25 | 4.43× | -0.25× | ||
| Q1 25 | 1.37× | 1.05× | ||
| Q4 24 | 3.58× | 5.31× | ||
| Q3 24 | 2.39× | 0.56× | ||
| Q2 24 | 2.18× | 1.25× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
ZION
Segment breakdown not available.
